-
-
-
-
-
-
-
AMAG Pharmaceuticals Announces Preliminary 2018 Financial Results and Provides 2019 Financial Guidance
-
-
-
-
-
-
-
Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
-
-
-
-
-
-
-
AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights
-
-
-
-
-
-
-
AMAG Pharma (AMAG) Issues Response to FDA CRL Regarding Makena
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

